A case of ketamine dependence with discontinuation symptoms

被引：39

作者：

Critchlow, Denise Gail ^{[1
]}

机构：

[1] Specialist Community Addict Serv, Rectory Ctr, Oxford OX4 1BU, England

来源：

ADDICTION | 2006年 / 101卷 / 08期

关键词：

PHARMACOLOGY; HUMANS;

D O I：

10.1111/j.1360-0443.2006.01494.x

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

100404 [儿少卫生与妇幼保健学];

摘要：

[No abstract available]

引用

收藏

页码：1212 / 1213

页数：2

相关论文

共 10 条

[1]

A brief overview of the clinical pharmacology of "club drugs" [J].

Britt, GC ;

McCance-Katz, EF .

SUBSTANCE USE & MISUSE, 2005, 40 (9-10) :1189-1201

[2]

Illicit use of ketamine in Scotland [J].

Dalgarno, PJ ;

Shewan, D .

JOURNAL OF PSYCHOACTIVE DRUGS, 1996, 28 (02) :191-199

[3]

FIDECKA S, 1989, POL J PHARMACOL PHAR, V41, P23

[4]

HURT PH, 1994, AM J PSYCHIAT, V151, P779

[5]

The nonmedical use of ketamine, part two: A review of problem use and dependence [J].

Jansen, KLR ;

Darracot-Cankovic, R .

JOURNAL OF PSYCHOACTIVE DRUGS, 2001, 33 (02) :151-158

[6]

SUBANESTHETIC EFFECTS OF THE NONCOMPETITIVE NMDA ANTAGONIST, KETAMINE, IN HUMANS - PSYCHOTOMIMETIC, PERCEPTUAL, COGNITIVE, AND NEUROENDOCRINE RESPONSES [J].

KRYSTAL, JH ;

KARPER, LP ;

SEIBYL, JP ;

FREEMAN, GK ;

DELANEY, R ;

BREMNER, JD ;

HENINGER, GR ;

BOWERS, MB ;

CHARNEY, DS .

ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) :199-214

[7]

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans [J].

Krystal, JH ;

Karper, LP ;

Bennett, A ;

D'Souza, DC ;

Abi-Dargham, A ;

Morrissey, K ;

Abi-Saab, D ;

Bremner, JD ;

Bowers, MB ;

Suckow, RF ;

Stetson, P ;

Heninger, GR ;

Charney, DS .

PSYCHOPHARMACOLOGY, 1998, 135 (03) :213-229

[8]

THE EXCITATORY AMINO-ACID RECEPTORS - THEIR CLASSES, PHARMACOLOGY, AND DISTINCT PROPERTIES IN THE FUNCTION OF THE CENTRAL NERVOUS-SYSTEM [J].

MONAGHAN, DT ;

BRIDGES, RJ ;

COTMAN, CW .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1989, 29 :365-402

[9]

Ketamine dependence [J].

Pal, HR ;

Berry, N ;

Kumar, R ;

Ray, R .

ANAESTHESIA AND INTENSIVE CARE, 2002, 30 (03) :382-384

[10]

*WHO EXP COMM DRUG, 2003, TECHN REP SER WHO, V915, P1